Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	346	626	692	385	914	137
Market Cap Growth	-48.04%	-9.43%	79.66%	-57.86%	566.67%	10.53%
Enterprise Value	342	623	747	385	913	140
Last Close Price	0.53	0.96	1.06	0.59	1.40	0.21
PE Ratio	23.12	-	35.83	84.53	-	-
PS Ratio	9.37	52.31	87.66	153.83	36.83	8.45
PB Ratio	0.35	0.68	1.22	0.71	1.69	0.25
P/TBV Ratio	0.35	0.68	1.22	0.71	1.69	0.25
P/OCF Ratio	-	-	35.57	22.59	65.34	3.47
EV/Sales Ratio	9.27	52.04	94.61	153.76	36.82	8.63
EV/EBIT Ratio	13.60	-	220.68	-	300.77	2821.15
Debt / Equity Ratio	-	-	-	-	-	0.00
Net Debt / Equity Ratio	0.00	-0.02	0	0.00	0.00	0.00
Asset Turnover	-	0.02	0.01	0.01	0.05	0.03
Quick Ratio	-	28.71	0.06	0.54	2.36	23.54
Current Ratio	-	29.65	0.30	0.65	2.37	23.64
Return on Equity (ROE)	-	-0.39%	3.48%	0.84%	-0.02%	-2.92%
Return on Assets (ROA)	-	-0.23%	0.38%	-0.22%	0.35%	0.01%
Return on Invested Capital (ROIC)	2.53%	-0.37%	0.61%	-0.35%	0.56%	0.01%
Return on Capital Employed (ROCE)	-	-0.30%	0.60%	-0.40%	0.60%	0.00%
Earnings Yield	7.21%	-0.47%	2.79%	1.18%	-0.01%	-11.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.